Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page
- Check5 days agoChange DetectedNew user guidance links were added to the page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was standardized and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check13 days agoChange DetectedThe study record now includes new sites in Vinnytsia, Uzhhorod, Lviv, and Seoul, increasing the total number of locations to 426, and it reflects updated statuses for several local institutions (including completed/withdrawn ones) and the addition of Site 1252 in Shelby, NC.SummaryDifference0.5%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a new revision of the page; this appears to be a minor update to the page metadata rather than a change to the study details.SummaryDifference0.0%

- Check34 days agoChange DetectedThe study locations list has expanded to 421 sites worldwide, with new institutions added (e.g., Khmelnytskyi, Ukraine; Kirkland, Washington; Zagreb, Croatia; Tampa, Florida) and existing entries updated. New investigator contacts and site details have been added, and recruitment statuses across sites have been clarified (Recruiting, Withdrawn, Completed).SummaryDifference0.8%

- Check48 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a new build of the page. This update serves to track revisions to the page's documentation.SummaryDifference0.0%

- Check56 days agoChange DetectedThe number of study locations increased (415 to 416) with corresponding additions/updates to specific site and local institution entries and their contact information (e.g., a new location/site in Ternopil, Ukraine and updated contacts). The page also reflects a newer record update date and revision entry.SummaryDifference0.5%

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.